{"id":848,"date":"2026-03-10T18:00:13","date_gmt":"2026-03-10T18:00:13","guid":{"rendered":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/"},"modified":"2026-03-10T18:00:13","modified_gmt":"2026-03-10T18:00:13","slug":"beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada","status":"publish","type":"post","link":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/","title":{"rendered":"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada"},"content":{"rendered":"<h1 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada<\/h1>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Most companies assume compliance ends once their product hits the market. You know better\u2014post-approval compliance demands constant attention to regulatory expectations from the FDA and Health Canada. Staying ahead means mastering ongoing compliance through rigorous post-market surveillance, change control, and vigilant quality management. This guide outlines best practices to keep your products compliant and your business secure beyond approval. <a href=\"https:\/\/hyperproof.io\/complete-guide-to-continuous-compliance\/\" target=\"_blank\">Learn more about continuous compliance here.<\/a><\/p>\n<h2 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Sustaining FDA and Health Canada Compliance<\/h2>\n<p><img decoding=\"async\" data-blockid=\"replaceWithId\" data-float=\"center\" data-href=\"\" src=\"https:\/\/blaze-media-uploads-for-dev.s3.us-west-1.amazonaws.com\/arora297consultancy-2754984292d07888692e.com_image_12\" alt=\"\" title=\"\" data-media-file-id=\"xWcJ7o9LFqFuGdaH9R4qaUlon4MAtu9i\" style=\"max-width: 100%;height: auto;display: block;margin: 0 auto;\"><\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Navigating post-approval compliance is like mastering a continuous dance. To stay in sync with the FDA and Health Canada, you need precise steps. This journey begins with understanding the key practices that sustain compliance.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Key Post-Approval Practices<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">You might think getting FDA approval is the final step, but it&#8217;s just the beginning. Post-approval practices ensure your product remains compliant and safe. Start with <strong>change control<\/strong>. This involves tracking any modifications to your product or processes. By documenting changes meticulously, you maintain quality and safety.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Next, focus on <strong>quality management systems (QMS)<\/strong>. Implement systems aligned with standards like <strong>ISO 13485<\/strong> or <strong>MDSAP<\/strong>. These help manage risks effectively. Regular audits and reviews keep your systems updated, ensuring continuous compliance.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Finally, establish a <strong>robust labeling update process<\/strong>. Regulatory changes can affect product labels. Keeping labels accurate prevents costly recalls and maintains trust. By integrating these practices, you secure your product&#8217;s market position.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Navigating Regulatory Changes<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Regulations evolve, and so should your compliance strategy. Keeping up with changes from FDA and Health Canada is crucial. Regular updates on regulatory changes help you stay informed. Subscribing to industry newsletters or joining professional groups can be beneficial.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">When a regulatory change occurs, assess its impact on your product. Does it require a formulation tweak or labeling update? <strong>Regulatory intelligence<\/strong> is your ally here. By anticipating these changes, you minimize disruptions.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Ensure your team is trained to handle new regulations. Workshops and training sessions keep everyone updated. This proactive approach not only keeps you compliant but also gives you a competitive edge in an ever-changing landscape.<\/p>\n<h2 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Effective Post-Market Surveillance<\/h2>\n<p><img decoding=\"async\" data-blockid=\"replaceWithId\" data-float=\"center\" data-href=\"\" src=\"https:\/\/blaze-media-uploads-for-dev.s3.us-west-1.amazonaws.com\/about-21d93e77786b258ff969.php_image_4\" alt=\"\" title=\"\" data-media-file-id=\"8J9zhhP246uLqaX6WgiiGdlooeNWvgLj\" style=\"max-width: 100%;height: auto;display: block;margin: 0 auto;\"><\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Now that you understand key practices, let&#8217;s dive into post-market surveillance. This process is vital for identifying risks and ensuring product safety long after approval.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Pharmacovigilance and Medical Device Vigilance<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Pharmacovigilance is essential for tracking drug safety. It involves collecting data on adverse effects and analyzing it for trends. By doing this, you protect consumers and maintain compliance with FDA and Health Canada. Establish a strong reporting system that encourages healthcare professionals and consumers to report issues.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">For medical devices, vigilance is equally critical. Monitor device performance and report any malfunctions. A robust monitoring system helps you detect and address potential issues before they escalate. This not only ensures safety but also builds trust with users.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Implementing these surveillance strategies helps you identify risks early. This proactive stance is key to maintaining ongoing compliance and protecting your brand&#8217;s reputation.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Complaint Handling and Trend Analysis<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Handling complaints effectively is a cornerstone of good compliance. Create a system that makes it easy for customers to voice concerns. Each complaint is an opportunity to improve your product and demonstrate your commitment to quality.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Analyze complaint data to identify trends. Are there recurring issues? What can you learn from them? By understanding these patterns, you can make informed decisions about product improvements and risk management.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Regular trend analysis allows you to anticipate potential problems and address them proactively. This approach not only keeps you compliant but also enhances customer satisfaction and loyalty.<\/p>\n<h2 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Strategic Compliance Solutions<\/h2>\n<p><img decoding=\"async\" data-blockid=\"replaceWithId\" data-float=\"center\" data-href=\"\" src=\"https:\/\/blaze-media-uploads-for-dev.s3.us-west-1.amazonaws.com\/arora297consultancy-1ceee6878b792a7bb5b8.com_image_11\" alt=\"\" title=\"\" data-media-file-id=\"VWUCkfPxa1HfmopbCZtdytwv7911QfPJ\" style=\"max-width: 100%;height: auto;display: block;margin: 0 auto;\"><\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">As you continue your compliance journey, strategic solutions become essential. These solutions offer a proactive approach to managing regulatory challenges.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Proactive Regulatory Intelligence<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Regulatory intelligence is about staying ahead. It involves continuously gathering information about regulatory trends and updates. This knowledge enables you to anticipate and adapt to changes swiftly.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Invest in tools that provide real-time regulatory insights. These can alert you to changes in FDA and Health Canada requirements. By acting on this information promptly, you avoid compliance lapses and maintain market presence.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Form partnerships with industry experts who can provide strategic guidance. Their insights help you navigate complex regulations and develop effective compliance strategies.<\/p>\n<h3 data-blockid=\"replaceWithId\" data-depth=\"0\" id=\"replaceWithId\">Recall Readiness and Supplier Audits<\/h3>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Being ready for a recall is crucial. Develop a recall plan that outlines steps to take in case of non-compliance. Regularly test this plan with mock recalls to ensure your team is prepared.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">Supplier audits are another vital component. Assess your suppliers&#8217; compliance with regulations. This ensures they meet quality standards and don&#8217;t jeopardize your product&#8217;s compliance.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">By focusing on recall readiness and conducting supplier audits, you protect your brand and maintain trust with consumers. These strategic solutions are integral to sustaining compliance and achieving long-term success.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">In summary, mastering post-approval compliance requires a combination of vigilance, proactive strategies, and continuous learning. By implementing these best practices, you can ensure your products remain compliant and competitive in the dynamic regulatory landscape.<\/p>\n<p data-blockid=\"replaceWithId\" data-depth=\"0\">\n","protected":false},"excerpt":{"rendered":"<p>Maintain ongoing FDA and Health Canada compliance post-approval through rigorous change control, quality management, regulatory intelligence, post-market surveillance, complaint analysis, recall readiness, and supplier audits.<\/p>\n","protected":false},"author":1,"featured_media":847,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[79],"tags":[532,805,398,402,397,808,80,807,804,162,368,406,63,369,809,408,383,87,806,396,84,387,655,401,88,810],"class_list":["post-848","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-avinash-k-arora","tag-510k-maintenance","tag-annual-product-review","tag-capa","tag-change-control","tag-complaint-handling","tag-din-maintenance","tag-fda-compliance","tag-field-safety-corrective-action","tag-gmp","tag-health-canada-compliance","tag-iso-13485","tag-labeling-updates","tag-mdel","tag-mdsap","tag-medical-device-licence-maintenance","tag-medical-device-vigilance","tag-nhp-licensing","tag-ongoing-compliance","tag-periodic-safety-update-report","tag-pharmacovigilance","tag-post-approval-compliance","tag-post-market-surveillance","tag-qms","tag-recall-readiness","tag-regulatory-intelligence","tag-supplier-audits"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 4.9.8 - aioseo.com -->\n\t<meta name=\"description\" content=\"Maintain ongoing FDA and Health Canada compliance post-approval through rigorous change control, quality management, regulatory intelligence, post-market surveillance, complaint analysis, recall readiness, and supplier audits.\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 4.9.8\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Arora 297 Consultancy - Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada - Arora 297 Consultancy\" \/>\n\t\t<meta property=\"og:description\" content=\"Maintain ongoing FDA and Health Canada compliance post-approval through rigorous change control, quality management, regulatory intelligence, post-market surveillance, complaint analysis, recall readiness, and supplier audits.\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-03-10T18:00:13+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-03-10T18:00:13+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/consultingwithoutboundaries\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada - Arora 297 Consultancy\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Maintain ongoing FDA and Health Canada compliance post-approval through rigorous change control, quality management, regulatory intelligence, post-market surveillance, complaint analysis, recall readiness, and supplier audits.\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\\\/#blogposting\",\"name\":\"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada - Arora 297 Consultancy\",\"headline\":\"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada\",\"author\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/featured-image-1773165608.jpeg\",\"width\":1920,\"height\":778},\"datePublished\":\"2026-03-10T18:00:13+00:00\",\"dateModified\":\"2026-03-10T18:00:13+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\\\/#webpage\"},\"articleSection\":\"Regulatory Insights, 510(k) maintenance, Annual Product Review, CAPA, change control, complaint handling, DIN maintenance, FDA compliance, field safety corrective action, GMP, Health Canada compliance, ISO 13485, labeling updates, MDEL, MDSAP, Medical Device Licence maintenance, medical device vigilance, NHP licensing, ongoing compliance, periodic safety update report, pharmacovigilance, post-approval compliance, post-market surveillance, QMS, recall readiness, regulatory intelligence, supplier audits\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/#listItem\",\"name\":\"Arora 297 Consultancy\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/#listItem\",\"position\":2,\"name\":\"Arora 297 Consultancy\",\"item\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/avinash-k-arora\\\/#listItem\",\"name\":\"Regulatory Insights\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/avinash-k-arora\\\/#listItem\",\"position\":3,\"name\":\"Regulatory Insights\",\"item\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/avinash-k-arora\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\\\/#listItem\",\"name\":\"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/#listItem\",\"name\":\"Arora 297 Consultancy\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\\\/#listItem\",\"position\":4,\"name\":\"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/category\\\/arora-297-consultancy\\\/avinash-k-arora\\\/#listItem\",\"name\":\"Regulatory Insights\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#organization\",\"name\":\"Arora Consultancy\",\"description\":\"Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/\",\"telephone\":\"+15194985957\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.arora297consultancy.com\\\/assets\\\/media\\\/general\\\/logo.png\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\\\/#organizationLogo\"},\"image\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/consultingwithoutboundaries\\\/\",\"https:\\\/\\\/www.instagram.com\\\/arora297consultancy\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/arora-297-consultancy\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/9c4b4c0b5727c4eaa4bbf02b476c099d4d7bb4a1fdceeafb6890a386e37d0bc6?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\\\/#webpage\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\\\/\",\"name\":\"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada - Arora 297 Consultancy\",\"description\":\"Maintain ongoing FDA and Health Canada compliance post-approval through rigorous change control, quality management, regulatory intelligence, post-market surveillance, complaint analysis, recall readiness, and supplier audits.\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/wp-content\\\/uploads\\\/2026\\\/03\\\/featured-image-1773165608.jpeg\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\\\/#mainImage\",\"width\":1920,\"height\":778},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\\\/#mainImage\"},\"datePublished\":\"2026-03-10T18:00:13+00:00\",\"dateModified\":\"2026-03-10T18:00:13+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/arora297consultancy.com\\\/blog\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada - Arora 297 Consultancy","description":"Maintain ongoing FDA and Health Canada compliance post-approval through rigorous change control, quality management, regulatory intelligence, post-market surveillance, complaint analysis, recall readiness, and supplier audits.","canonical_url":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/#blogposting","name":"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada - Arora 297 Consultancy","headline":"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada","author":{"@id":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/arora297consultancy.com\/blog\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/arora297consultancy.com\/blog\/wp-content\/uploads\/2026\/03\/featured-image-1773165608.jpeg","width":1920,"height":778},"datePublished":"2026-03-10T18:00:13+00:00","dateModified":"2026-03-10T18:00:13+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/#webpage"},"isPartOf":{"@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/#webpage"},"articleSection":"Regulatory Insights, 510(k) maintenance, Annual Product Review, CAPA, change control, complaint handling, DIN maintenance, FDA compliance, field safety corrective action, GMP, Health Canada compliance, ISO 13485, labeling updates, MDEL, MDSAP, Medical Device Licence maintenance, medical device vigilance, NHP licensing, ongoing compliance, periodic safety update report, pharmacovigilance, post-approval compliance, post-market surveillance, QMS, recall readiness, regulatory intelligence, supplier audits"},{"@type":"BreadcrumbList","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog#listItem","position":1,"name":"Home","item":"https:\/\/arora297consultancy.com\/blog","nextItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/#listItem","name":"Arora 297 Consultancy"}},{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/#listItem","position":2,"name":"Arora 297 Consultancy","item":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/","nextItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/avinash-k-arora\/#listItem","name":"Regulatory Insights"},"previousItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/avinash-k-arora\/#listItem","position":3,"name":"Regulatory Insights","item":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/avinash-k-arora\/","nextItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/#listItem","name":"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada"},"previousItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/#listItem","name":"Arora 297 Consultancy"}},{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/#listItem","position":4,"name":"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada","previousItem":{"@type":"ListItem","@id":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/avinash-k-arora\/#listItem","name":"Regulatory Insights"}}]},{"@type":"Organization","@id":"https:\/\/arora297consultancy.com\/blog\/#organization","name":"Arora Consultancy","description":"Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance","url":"https:\/\/arora297consultancy.com\/blog\/","telephone":"+15194985957","logo":{"@type":"ImageObject","url":"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/#organizationLogo"},"image":{"@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/consultingwithoutboundaries\/","https:\/\/www.instagram.com\/arora297consultancy\/","https:\/\/www.linkedin.com\/company\/arora-297-consultancy\/"]},{"@type":"Person","@id":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/#author","url":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/9c4b4c0b5727c4eaa4bbf02b476c099d4d7bb4a1fdceeafb6890a386e37d0bc6?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/#webpage","url":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/","name":"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada - Arora 297 Consultancy","description":"Maintain ongoing FDA and Health Canada compliance post-approval through rigorous change control, quality management, regulatory intelligence, post-market surveillance, complaint analysis, recall readiness, and supplier audits.","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/arora297consultancy.com\/blog\/#website"},"breadcrumb":{"@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/#breadcrumblist"},"author":{"@id":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/#author"},"creator":{"@id":"https:\/\/arora297consultancy.com\/blog\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/arora297consultancy.com\/blog\/wp-content\/uploads\/2026\/03\/featured-image-1773165608.jpeg","@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/#mainImage","width":1920,"height":778},"primaryImageOfPage":{"@id":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/#mainImage"},"datePublished":"2026-03-10T18:00:13+00:00","dateModified":"2026-03-10T18:00:13+00:00"},{"@type":"WebSite","@id":"https:\/\/arora297consultancy.com\/blog\/#website","url":"https:\/\/arora297consultancy.com\/blog\/","name":"Blog","description":"Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance","inLanguage":"en-US","publisher":{"@id":"https:\/\/arora297consultancy.com\/blog\/#organization"}}]},"og:locale":"en_US","og:site_name":"Arora 297 Consultancy - Unlocking Insights, Empowering Success: Your Trusted Source for Regulatory Guidance and Compliance","og:type":"article","og:title":"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada - Arora 297 Consultancy","og:description":"Maintain ongoing FDA and Health Canada compliance post-approval through rigorous change control, quality management, regulatory intelligence, post-market surveillance, complaint analysis, recall readiness, and supplier audits.","og:url":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/","og:image":"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png","og:image:secure_url":"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png","article:published_time":"2026-03-10T18:00:13+00:00","article:modified_time":"2026-03-10T18:00:13+00:00","article:publisher":"https:\/\/www.facebook.com\/consultingwithoutboundaries\/","twitter:card":"summary_large_image","twitter:title":"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada - Arora 297 Consultancy","twitter:description":"Maintain ongoing FDA and Health Canada compliance post-approval through rigorous change control, quality management, regulatory intelligence, post-market surveillance, complaint analysis, recall readiness, and supplier audits.","twitter:image":"https:\/\/www.arora297consultancy.com\/assets\/media\/general\/logo.png"},"aioseo_meta_data":{"post_id":"848","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-05-26 17:59:43","updated":"2026-05-26 17:59:43","seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/arora297consultancy.com\/blog\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/\" title=\"Arora 297 Consultancy\">Arora 297 Consultancy<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/avinash-k-arora\/\" title=\"Regulatory Insights\">Regulatory Insights<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tBeyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/arora297consultancy.com\/blog"},{"label":"Arora 297 Consultancy","link":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/"},{"label":"Regulatory Insights","link":"https:\/\/arora297consultancy.com\/blog\/category\/arora-297-consultancy\/avinash-k-arora\/"},{"label":"Beyond Approval: Best Practices to Maintain Ongoing Compliance in the US and Canada","link":"https:\/\/arora297consultancy.com\/blog\/beyond-approval-best-practices-to-maintain-ongoing-compliance-in-the-us-and-canada\/"}],"_links":{"self":[{"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/posts\/848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/comments?post=848"}],"version-history":[{"count":0,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/posts\/848\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/media\/847"}],"wp:attachment":[{"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/media?parent=848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/categories?post=848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/arora297consultancy.com\/blog\/wp-json\/wp\/v2\/tags?post=848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}